CHCT NYSE Week ended 31 Jul 2026

Weekly Investor Report

Community Healthcare Trust Inc · Real Estate · Reit - Healthcare Facilities

Open interactive chart View report data
Latest close 18.31 USD
-2.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 8.1% above the Trend Line and sits at 87.9% of its 52-week range. The latest completed week returned -2.6%, after a 0.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 39/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 3d.

Setup score 63 out of 100
Latest Close 18.31 USD 31 Jul 2026
1W Return -2.6% latest completed week
4W Return 0.0% short-term follow-through
12W Return 7.1% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 30-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 44.80% based on similar historical setup states.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.6% Latest completed week; four-week move 0.0%. Indicator stack 77/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.80% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 39/100 conviction; expected move 13.0%. News sentiment 54/100 52 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.1% above the Trend Line and sits at 87.9% of its 52-week range. The latest completed week returned -2.6%, after a 0.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9612-week average 0.81

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.96Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.0% over four weeks, 7.1% over 12 weeks, and 34.8% over one year. The current trend has remained active for 30 consecutive weeks.

Performance by holding period

1W-2.6%
4W0.0%
12W7.1%
26W12.2%
52W34.8%
Active trend streak30 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.17Latest activity-pressure read.
Pressure change15.2%Four-week change in activity pressure.
Leadership7.72Latest relative-leadership reading.
RS change-10.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength51/100Blend of value, momentum, and quality. Underlying universe rank 50; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality78/100Profitability and accounting quality. Underlying universe rank 23; rank 1 is best.
Momentum75/100Medium-term price momentum. Underlying universe rank 26; rank 1 is best.
Growth9/100Revenue and earnings growth. Underlying universe rank 92; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
88.6x
Price divided by trailing earnings.
Price / sales
4.4x
Market value relative to trailing revenue.
EV / EBITDA
14.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
62.8%
Gross profit retained from each unit of revenue.
Operating margin
28.7%
Operating profit retained from revenue.
Free-cash-flow margin
68.7%
Free cash flow generated from revenue.
Return on invested capital
3.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-1.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
10.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
10.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
7.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

CHCT shows mixed options pressure with a 39/100 conviction score, put-call volume ratio of 1.60, expected move of 13.0%, and Sharemaestro trend signal active.

Conviction39/100
Expected move13.0%
Put/call volume1.60
Pressure-14
Speculation16
Volatility73
Trend agreement87
Open options detail
Insider activity10 / 3

10 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 52 relevant articles.

12 positive · 35 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move13.0%Nearest-chain priced movement where available.
52-week drawdown-4.5%Distance below the 52-week high.
13-week volatility2.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+6.6%Week of 10 Apr.
Worst week-3.8%Week of 20 Mar.
Latest week-2.6%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains7
Flat weeks0
Modest losses15
Sharp losses0
Recent vol2.5%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

 Indicator analysis87/100

Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 12/12.

Activity pressure 0.96; No reversal markers Next-Week ExpectancyNegative 44.80%

Next-week expectancy is negative with a 44.80% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 63; Small Cap Core rank 65 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options58/100

CHCT shows mixed options pressure with a 39/100 conviction score, put-call volume ratio of 1.60, expected move of 13.0%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 13.0% Sentiment54/100

Weighted news tone is neutral across 52 relevant articles.

Community Healthcare Trust Incorporated Revenue Breakdown – NYSE:CHCT Insiders10 / 3

10 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202618.31 USD-2.6%16.94 USD17.17 USD1.177.721.0MOn
24 Jul 202618.79 USD-0.1%16.85 USD17.22 USD1.1611.99997.8KOn
17 Jul 202618.81 USD4.4%16.72 USD17.27 USD1.2611.651.0MOn
10 Jul 202618.01 USD-1.6%16.60 USD17.32 USD1.115.451.1MOn
3 Jul 202618.31 USD-0.1%16.48 USD17.38 USD1.018.61685.5KOn
26 Jun 202618.33 USD5.2%16.35 USD17.43 USD0.8611.041.3MOn
19 Jun 202617.43 USD-2.7%16.23 USD17.47 USD0.533.15779.4KOn
12 Jun 202617.91 USD2.4%16.12 USD17.51 USD0.416.80625.8KOn
5 Jun 202617.49 USD1.6%15.99 USD17.56 USD0.164.81798.0KOn
29 May 202617.22 USD-0.9%15.86 USD17.61 USD0.070.49650.8KOn
22 May 202617.38 USD3.0%15.74 USD17.67 USD-0.022.71881.1KOn
15 May 202616.87 USD-1.3%15.60 USD17.71 USD-0.060.471.1MOn
8 May 202617.09 USD-0.2%15.46 USD17.76 USD-0.031.801.3MOn
1 May 202617.12 USD2.4%15.30 USD17.82 USD-0.134.17792.9KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.